Chronic Kidney Diseases Clinical Trial
The objective of this study will be to evaluate the effects of neuromuscular electrical stimulation of high and low frequency and intensity, performed during hemodialysis (HD), on peripheral muscle strength, exercise capacity and muscle change and inflammation markers in patients with chronic kidney disease (CKD).
Clinical trial, randomized, parallel, open, two-arm, blinded assessor, prospective.
Patients with chronic kidney disease on hemodialysis, divided equally into two groups: group
of high frequency and intensity neuromuscular electrical stimulation (HG) and a group of low
frequency and intensity neuromuscular electrical stimulation (LG).
Randomization was stratified according to gender using 4 block. Drug treatment established
for both groups remained unchanged throughout the study period.
Assessments were made on the first working day after hemodialysis, following notification
and consent of the medical teams. Patients initially underwent anthropometric measurements
and vital signs, later carried out the assessment of peripheral muscle strength, pulmonary
function test, submaximal exercise capacity and quality of life questionnaire and
depression. After these procedures, the patients were randomized to select HG or LG by
opaque envelopes. These evaluations were performed at baseline and after 12 sessions of
completion of the protocol.
Furthermore, it was asked to chronic kidney disease (CKD) patients on hemodialysis who
presented their latest blood tests clearance index (Kt / V), creatinine, glomerular
filtration rate. The evaluation of pro-inflammatory cytokines and regulatory plasma, the
enzyme markers of muscle tropism, oxidative stress and muscle injury in patients with CKD
was always held at the end of each month as routine clinical.
Two groups conducted training with peripheral electrical stimulation isometric form in
lateral and medial bilaterally vast, held three times a week, lasting an hour, the first two
hours of dialysis.
Will be applied using portable stimulators with 4 channels. The parameters are:
- HG: frequency of 50 Hertz (Hz), pulse width of 400 microseconds (μs), rise time and
fall time of 2 seconds (s), on:off stimulation, initially with a 1:2 relation in the
first week (10s of stimulation and 20s of rest, with the objective to adapt and
minimize the effects of muscular fatigue), to be increased to a 1:1 relation in the
second week (10s of stimulation of and 10s of rest).
- LG: frequency of 5 Hz, on:off stimulation time of 1:3 (10s of stimulation and 30s of
rest) with pulse duration of 100 μs.
For both groups, the current intensity was adjusted individually in the first application.
In HG, the intensity was gradually increased until visible muscle contraction could be
observed: this was the maximum intensity tolerated by the patient. In LG, the intensity was
the least noticeable by the patient. These values were monitored for further calculation of
intensity evolution throughout the training program.
The blood pressure (BP) will be measured at baseline, and 30 minutes after the end of the
session and heart rate (HR) will be monitored every 10 minutes using an oximeter.
In each session there will be a warm-up period, training and slowdown. The first minute will
starting with 20% of the intensity value used in the last session with a gradual increase of
20% per minute until 5 minutes, followed by a 50 minute training period and finishing with a
5 minute recovery period gradual reduction of 20% intensity every minute.
Before and after training, patients will be asked about their feelings of fatigue /
tiredness of the lower limbs using the modified Borg scale. If reporting muscle pain, the
intensity will be assessed by visual analogue scale visual analogue scale (VAS).
They are recruited 76 patients of both sexes, accepted for hemodialysis treatment for at
least 6 months. 38 patients are allocated for the HG and 38 to LG.
The sample size calculation was performed in order to advance in GPower 3.1 program based on
the results obtained in the study conducted neuromuscular electrical stimulation during
hemodialysis in patients with chronic kidney disease. the values of peripheral muscle
strength were used before and after treatment respectively 185.4 ± 53 and 222.4 ± 36.6 and
the values for the assessment of pre exercise capacity (401.3 ± 55) and post (428.9 ± 69.2)
waiting for electrostimulation observe a similar effect. Using an error of 5% (80% test
power), it was determined the need for inclusion of 12 patients for the variable peripheral
muscle strength and 34 patients for exercise capacity. Recital 10% loss would require the
evaluation and treatment of 14 and 38 patients to check the effect on peripheral muscle
strength and on exercise capacity respectively.
Safety:
The main negative effect of electrical stimulation is muscle discomfort and / or fatigue of
the lower limbs during and after training. Patients will be were asked at the beginning and
end of the training on their sense of fatigue / tiredness members, as well as on the feeling
of muscle pain. In addition, the current was adjusted individually and gradually increased
shape with patient consent. In the case that patients feel a discomfort, the intensity of
electric current was reduced, and if required the protocol was stopped by improvement of
symptoms.
Statistical analysis:
The data were systematized in IBM SPSS (Statistical Package for Social Sciences) version
20.0. The data were presented as mean ± standard deviation or median and interquartile range
and frequency. To verify the data normality the Shapiro-Wilk test was applied. To compare
the behavior of the variables between groups was used independent t test for parametric
variables and test U Mann Whitney for nonparametric. As for comparing the average pre and
post use of electrical stimulation was used ANOVA test for repeated measurements or Friedman
test and to check if there is a relationship between respiratory muscle strength and
exercise capacity was used Pearson correlation coefficient or Spearman, according to the
normal distribution of data. The significance level for the statistical treatment was 5% (p
<0.05).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06386172 -
Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm
|
N/A | |
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT03434145 -
Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases
|
N/A | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Terminated |
NCT05022329 -
COVID-19 Vaccine Boosters in Patients With CKD
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04925661 -
HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
|
Phase 1 | |
Recruiting |
NCT04961164 -
Resistant Starch Prebiotic Effects in Chronic Kidney Disease
|
N/A | |
Completed |
NCT05015647 -
Low Protein Diet in CKD Patients at Risk of Malnutrition
|
N/A | |
Completed |
NCT03426787 -
Helping Empower Liver and Kidney Patients
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Completed |
NCT04363554 -
The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease
|
N/A | |
Recruiting |
NCT04831021 -
Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role?
|
N/A | |
Terminated |
NCT04877847 -
Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury
|
N/A | |
Recruiting |
NCT04422652 -
Combination of Novel Therapies for CKD Comorbid Depression
|
Phase 2 | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Not yet recruiting |
NCT06330480 -
Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT03176862 -
Left Ventricular Fibrosis in Chronic Kidney Disease
|
N/A | |
Terminated |
NCT02539680 -
Intestinal Phosphate Transporter Expression in CKD Patients
|
N/A |